Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter R Carroll

Showing results (91-100 of 589) with videos related to

Pageof 59
Sort By:
Cancer|May 23, 2007
Initial treatment patterns and outcome of contemporary prostate cancer patients with bone metastases at initial presentation: data from CaPSURECharles J Ryan, Eric P Elkin, Janet Cowan, et al.
BJU International|June 25, 2009
Adequacy of lymphadenectomy among men undergoing robot-assisted laparoscopic radical prostatectomyMatthew R Cooperberg, Christopher J Kane, Janet E Cowan, et al.
Cancer|August 7, 2010
Comparative risk-adjusted mortality outcomes after primary surgery, radiotherapy, or androgen-deprivation therapy for localized prostate cancerMatthew R Cooperberg, Andrew J Vickers, Jeanette M Broering, et al.
The Journal of Urology|January 22, 2008
A model that predicts the probability of positive imaging in prostate cancer cases with biochemical failure after initial definitive local therapyToni K Choueiri, Robert Dreicer, Alan Paciorek, et al.
Journal of the National Cancer Institute. Monographs|December 29, 2012
Role of active surveillance in the management of localized prostate cancerAllison S Glass, Matthew R Cooperberg, Maxwell V Meng, et al.
The Journal of Urology|July 24, 2007
Contemporary trends in low risk prostate cancer: risk assessment and treatmentMatthew R Cooperberg, Jeannette M Broering, Philip W Kantoff, et al.
Urologic Oncology|January 28, 2009
Sequential intravesical gemcitabine and mitomycin C chemotherapy regimen in patients with non-muscle invasive bladder cancerBenjamin N Breyer, Jared M Whitson, Peter R Carroll, et al.
The Journal of Urology|November 17, 2009
Eligibility for active surveillance and pathological outcomes for men undergoing radical prostatectomy in a large, community based cohortMarc C Smaldone, Janet E Cowan, Peter R Carroll, et al.
Urology Practice|May 25, 2023
A Novel Standardized Morbidity and Mortality Process to Promote Discourse, Improve Education, and Facilitate Practice Change: The M-PROVE ModelMax Bowman, Heiko Yang, Justin Ahn, et al.
World Journal of Urology|February 25, 2011
The example of CaPSURE: lessons learned from a national disease registrySima P Porten, Matthew R Cooperberg, Badrinath R Konety, et al.
Pageof 59

Showing results (91-100 of 589) with videos related to

Sort By:
Pageof 59
Cancer|May 23, 2007
Initial treatment patterns and outcome of contemporary prostate cancer patients with bone metastases at initial presentation: data from CaPSURECharles J Ryan, Eric P Elkin, Janet Cowan, et al.
BJU International|June 25, 2009
Adequacy of lymphadenectomy among men undergoing robot-assisted laparoscopic radical prostatectomyMatthew R Cooperberg, Christopher J Kane, Janet E Cowan, et al.
Cancer|August 7, 2010
Comparative risk-adjusted mortality outcomes after primary surgery, radiotherapy, or androgen-deprivation therapy for localized prostate cancerMatthew R Cooperberg, Andrew J Vickers, Jeanette M Broering, et al.
The Journal of Urology|January 22, 2008
A model that predicts the probability of positive imaging in prostate cancer cases with biochemical failure after initial definitive local therapyToni K Choueiri, Robert Dreicer, Alan Paciorek, et al.
Journal of the National Cancer Institute. Monographs|December 29, 2012
Role of active surveillance in the management of localized prostate cancerAllison S Glass, Matthew R Cooperberg, Maxwell V Meng, et al.
The Journal of Urology|July 24, 2007
Contemporary trends in low risk prostate cancer: risk assessment and treatmentMatthew R Cooperberg, Jeannette M Broering, Philip W Kantoff, et al.
Urologic Oncology|January 28, 2009
Sequential intravesical gemcitabine and mitomycin C chemotherapy regimen in patients with non-muscle invasive bladder cancerBenjamin N Breyer, Jared M Whitson, Peter R Carroll, et al.
The Journal of Urology|November 17, 2009
Eligibility for active surveillance and pathological outcomes for men undergoing radical prostatectomy in a large, community based cohortMarc C Smaldone, Janet E Cowan, Peter R Carroll, et al.
Urology Practice|May 25, 2023
A Novel Standardized Morbidity and Mortality Process to Promote Discourse, Improve Education, and Facilitate Practice Change: The M-PROVE ModelMax Bowman, Heiko Yang, Justin Ahn, et al.
World Journal of Urology|February 25, 2011
The example of CaPSURE: lessons learned from a national disease registrySima P Porten, Matthew R Cooperberg, Badrinath R Konety, et al.
Pageof 59